For example, in patients with metastatic renal cell cancer treated with an mTOR inhibitor everolimus, the 2-week relative changes of 18F-FDG uptake (SUVmax) from baseline were predictive of the 8-week change in tumor size as evaluated by conventional computed tomography.204. The gene discussed is MTOR; the disease is neoplasm.